Trial · NCT06658522
Registered outcomes15
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 15 of 15
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Power per beat | From enrollment to end of study at 24 weeks | mean pulmonary arery pressure (mPAP) x stroke volume (SV) |
| Primary | Right ventricular pulmonary artery coupling | From enrollment to end of study at 24 weeks | End systolic elastance (Ees)/ Arterial elastance (Ea) as derived from pressure-volume loops using right heart catheterization |
| Secondary | Right ventricular end systolic volume | From enrollment to the end of study at 24 weeks | Right ventricular end systolic volume as measured by cardiac magnetic resonance imaging |
| Secondary | Right ventricular end diastolic volume | From enrollment to the end of study at 24 weeks | Right ventricular end diastolic volume as measured by cardiac magnetic resonance imaging |
| Secondary | Right ventricular ejection fraction | From enrollment to the end of study at 24 weeks | Right ventricular ejection fraction as measured by cardiac magnetic resonance imaging |
| Secondary | Right ventricular mass | From enrollment to the end of study at 24 weeks | Right ventricular mass as measured by cardiac magnetic resonance imaging |
| Secondary | Stroke volume | From enrollment to the end of study at 24 weeks | Stroke volume as measured by cardiac magnetic resonance imaging derived aortic flow |
| Secondary | Left ventricular end diastolic volume | From enrollment to the end of study at 24 weeks | Left ventricular end diastolic volume as measured by cardiac magnetic resonance imaging |
| Secondary | Left ventricular end systolic volume | From enrollment to the end of study at 24 weeks | Left ventricular end systolic volume as measured by cardiac magnetic resonance imaging |
| Secondary | Left ventricular ejection fraction | From enrollment to the end of study at 24 weeks | Left ventricular ejection fraction as measured by cardiac magnetic resonance imaging |
| Secondary | Left ventricular mass | From enrollment to the end of study at 24 weeks | Left ventricular mass as measured by cardiac magnetic resonance imaging |
| Secondary | End-systolic elastance (Ees) | From enrollment to the end of study at 24 weeks | End systolic elastance measured using pressure-volume loops derived from right heart catheteriazation |
| Secondary | Arterial elastance (Ea) | From enrollment to the end of study at 24 weeks | Arterial elastance measured using pressure-volume loops derived from right heart catheteriazation |
| Secondary | End-diastolic elastance (Eed) | From enrollment to the end of study at 24 weeks | End-diastolic elastance measured using pressure-volume loops derived from right heart catheteriazation |
| Secondary | Right ventricular fibrosis | From enrollment to the end of study at 24 weeks | Righ ventricular fibrosis derived from extracellular volume measurements using Modified Look-Locker inversion recovery MRI sequence |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06658522/registered